William Blair Issues Negative Outlook for VTGN Earnings
VistaGen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) – Equities researchers at William Blair cut their Q1 2026 earnings estimates for shares of VistaGen Therapeutics in a research report issued on Wednesday, June 18th. William Blair analyst M. Minter now expects that the company will earn ($0.44) per share for the quarter, down from their prior […]
VistaGen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) – Equities researchers at William Blair cut their Q1 2026 earnings estimates for shares of VistaGen Therapeutics in a research report issued on Wednesday, June 18th. William Blair analyst M. Minter now expects that the company will earn ($0.44) per share for the quarter, down from their prior […]
